Home › Acute Lymphoblastic Leukemia › Florida › Orlando
Acute Lymphoblastic Leukemia clinical trials in Orlando, FL
4 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Arnold Palmer Hospital for Children, Orlando
- Nemours Children's Hospital, Orlando
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- AdventHealth Orlando, Orlando
- Florida Center for Pediatric Cellular Therapy, Orlando
- Orlando Health Arnold Palmer Hospital for Children, Orlando
- and 1 more
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
RecruitingPhase 1/2
- Arnold Palmer Hospital for Children, Orlando
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Nemours Children's Hospital, Orlando
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Seattle, WA21 studies
- Baldwin Park, CA21 studies
- Chicago, IL19 studies
- Atlanta, GA18 studies
- Memphis, TN16 studies
- Philadelphia, PA16 studies
- Washington, DC16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Metastatic Cancer29 studies
- Obesity29 studies
- Cancer (all types)25 studies
- Alzheimer's Disease25 studies
- Overweight25 studies
- Type 2 Diabetes24 studies
- Breast Cancer23 studies
- Ulcerative Colitis23 studies
- Ovarian Cancer22 studies
- Lung Cancer21 studies
- Major Depressive Disorder19 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.